B. Caleb

发表

Increased survival in experimental dog heatstroke after reduction of gut flora.

G. Bynum, J. Brown, D. Dubose, 1979, Aviation, space, and environmental medicine.

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

M. Warmuth, Shouyong Peng, O. Abdel-Wahab, 2018, Nature Medicine.

Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells [published erratum appears in J Cell Biol 1990 Mar;110(3):863]

B. Caleb, M. Karnovsky, J. Castellot, 1989, The Journal of cell biology.

Heparin binding, internalization, and metabolism in vascular smooth muscle cells: I. Upregulation of heparin binding correlates with antiproliferative activity

B. Caleb, D. Letourneur, J. Castellot, 1995, Journal of cellular physiology.

Discovery of Aminopyrazole Derivatives as Potent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3.

B. Caleb, N. Larsen, Tuong-Vi Nguyen, 2020, ACS medicinal chemistry letters.

H3B-8800, an Orally Bioavailable Modulator of the SF3b Complex, Shows Efficacy in Spliceosome-Mutant Myeloid Malignancies

M. Warmuth, O. Abdel-Wahab, B. Caleb, 2016 .

Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin

M. Hardenbrook, B. Caleb, J. Castellot, 1996, Journal of cellular physiology.

Binding and internalization of heparin by vascular smooth muscle cells

B. Caleb, M. Karnovsky, D. Albertini, 1985, Journal of cellular physiology.

Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex

M. Warmuth, Shouyong Peng, B. Caleb, 2017, Nature Communications.

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

Stephen Green, B. Caleb, G. Schwartz, 2008, Molecular Cancer Therapeutics.

Heparin binding, internalization, and metabolism in vascular smooth muscle cells: II. Degradation and secretion in sensitive and resistant cells

B. Caleb, D. Letourneur, J. Castellot, 1995, Journal of cellular physiology.

Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer.

M. Hao, M. Warmuth, B. Caleb, 2018, Cancer discovery.

Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.

B. Caleb, M. Karnovsky, J. Castellot, 1990, Cell regulation.

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

M. Warmuth, Shouyong Peng, O. Abdel-Wahab, 2018, Nature Medicine.

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

B. Caleb, G. Schwartz, J. Janetka, 2008, Molecular Cancer Therapeutics.